Tilray Brands (TLRY) Cost of Revenue (2017 - 2026)
Tilray Brands (TLRY) reported Cost of Revenue of $151.8 million for Q1 2026, up 991.54% on a YoY basis from $13.9 million in Q1 2025, and up 1188.33% quarter-over-quarter from $11.8 million in Q4 2025.
Tilray Brands (TLRY) Cost of Revenue (2017 - 2026) Analysis & Trends
Tilray Brands has reported Cost of Revenue for 10 years, with the latest figure at $151.8 million in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue rose 991.54% year-over-year to $151.8 million; the trailing twelve-month figure through Feb 2026 stood at $190.8 million (up 348.22% YoY), and the FY2025 full-year result was $56.0 million, up 50.51% from the prior year.
- Cost of Revenue for Q1 2026 stood at $151.8 million, up from $11.8 million in the prior quarter.
- The five-year high for Cost of Revenue was $151.8 million in Q1 2026, with the low at -$380.8 million in Q2 2024.
- Historically, Cost of Revenue has averaged $30.6 million across 5 years, with a median of $12.9 million in 2025.
- The largest YoY upside for Cost of Revenue was 2053.5% in 2024 against a maximum downside of 425.42% in 2024.
- Tilray Brands' Cost of Revenue stood at $101.3 million in 2022, then plunged by 92.51% to $7.6 million in 2023, then jumped by 1874.55% to $149.7 million in 2024, then plunged by 92.13% to $11.8 million in 2025, then surged by 1188.33% to $151.8 million in 2026.
- The last three Cost of Revenue figures came in at $151.8 million (Q1 2026), $11.8 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 151.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 151.78 Mn |
| Feb 28, 2026 | 151.78 Mn |
| Nov 30, 2025 | 11.78 Mn |
| Nov 30, 2025 | 11.78 Mn |
| Aug 31, 2025 | 12.92 Mn |
| Aug 31, 2025 | 12.92 Mn |
| May 31, 2025 | 14.28 Mn |
| May 31, 2025 | 14.28 Mn |
| Feb 28, 2025 | 13.91 Mn |
| Feb 28, 2025 | 13.91 Mn |
| Nov 30, 2024 | 149.73 Mn |
| Nov 30, 2024 | 149.73 Mn |
| Aug 31, 2024 | 140.34 Mn |
| Aug 31, 2024 | 140.34 Mn |
| May 31, 2024 | -380.83 Mn |
| May 31, 2024 | -380.83 Mn |
| Feb 29, 2024 | 138.94 Mn |
| Feb 29, 2024 | 138.94 Mn |
| Nov 30, 2023 | 7.58 Mn |
| Nov 30, 2023 | 7.58 Mn |